AstraZeneca Symbicort shows similar safety profile as Budesonide for asthma
In a 52-week study in African-American patients with moderate-to-severe persistent asthma, the company found that headache, nasopharyngitis, sinusitis and viral upper respiratory tract infection were the most common
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.